Abstract

Tick-borne encephalitis virus (TBEV) is a tick-transmitted arbovirus that causes serious diseases in humans in Europe and Northern Asia. About 6000–10,000 cases are registered annually, and one-third of them lead to sequela with different degrees of severity. Two TBEV strains (Absettarov and EK-328) similar in virulence rate in laboratory mice were used to study pathogenesis and immune response upon lethal infection in mice. The strains differed in the dynamics of appearance of virus, IFNs and other cytokines in blood of mice, and ability to induce a cytokine storm in the terminal stages of disease and a non-sterile immunity. Moreover, the TBEV strains differed in characteristics of their interactions with DCs: level of reproduction in these cells, virus dose triggering IFN-α production, and impact on DCs' maturation. Infection of DCs with Absettarov strain led to IFN-α induction only at high multiplicity of infection (MOI), and an increased amount of the mature DCs with high adhesion activity and low-level of MHCII positive cells. While reproduction of the EK-328 strain in DCs was less efficient, a low dose of the virus induced IFN-α production and stimulated maturation of DCs with relatively low adhesive capacity, but with the high percentage of cells expressing MHCII molecules. Thus, the studied strains differed significantly in the impact on DCs' maturation and antigen presentation to CD4+ lymphocytes. Injection of low (103 PFU) and high (106 PFU) doses of both TBEV strains caused a lethal infection in mice. At the same time, the dose of the virus in the inoculum, regardless of the strain properties, affected the following virulence characteristics: the time of virus appearance in brain (day 4–5 vs. day 1 p.i.), time of IFN-α appearance in blood (10 h vs. 5 h p.i.), concentration of IFN-α in blood, and induction of IFN-α during infection of DCs. Therefore, virulent TBEV strains during lethal infection can interact differently with the host immune system, and the infectious dose has an impact on both: virus spread in the infected organism and immune response activation.

Highlights

  • Tick-borne encephalitis (TBE) is one of the most serious arboviral human diseases in Europe and Northern Asia affecting the CNS

  • IP injection of the virus from culture supernate (CS) caused the death of 50% of animals with an infectious dose of 2.8 log10PFU, while the infectious dose for the virus obtained from the brain was 0.6 log10PFU (P < 0.05; Table 1, index c)

  • A clarification of the factors determining the outcome of the human contact with Tick-borne encephalitis virus (TBEV) is a key for understanding of the pathogenesis of infection, identification of virulence determinants, and even evaluation of the epidemiological situation in the natural foci

Read more

Summary

Introduction

Tick-borne encephalitis (TBE) is one of the most serious arboviral human diseases in Europe and Northern Asia affecting the CNS. Human infection usually occurs after a tick bite and results in cases with different outcomes, from asymptomatic infection to severe meningitis, meningoencephalitis, and encephalitis that can be fatal or can transform into a chronic disease. TBE pathogenesis has been studied in detail on materials from patients with different forms of disease (Shapoval, 1961; Erman et al, 2001; Kaiser, 2008). Activation of the immune system and brain inflammatory reaction in TBE patients has been estimated by measuring the level of the corresponding cytokines, enzymes, and other factors in blood and cerebrospinal fluid (Timofeev et al, 2002; Atrasheuskaya et al, 2003; Palus et al, 2015; Grygorczuk et al, 2016). Animal models allow reducing the influence of genetic diversity and immune status of test subjects and infectious doses of the virus and facilitate the ability to follow the initial stages of virus reproduction and activation of the immune responses

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call